These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fe(III)-EHPG and Fe(III)-5-Br-EHPG as contrast agents in MRI: an animal study. Liu GC; Wang YM; Jaw TS; Chen HM; Sheu RS J Formos Med Assoc; 1993 Apr; 92(4):359-66. PubMed ID: 8104585 [TBL] [Abstract][Full Text] [Related]
3. Investigation of physicochemical and in-vivo behavior of diastereomeric iron-59, gallium-68, and indium-111-EHPG trivalent metal complexes. Madsen SL; Bannochie CJ; Martell AE; Mathias CJ; Welch MJ J Nucl Med; 1990 Oct; 31(10):1662-8. PubMed ID: 2213190 [TBL] [Abstract][Full Text] [Related]
5. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
6. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging. Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022 [TBL] [Abstract][Full Text] [Related]
7. Tridentate facial ligation of tris(pyridine-2-aldoximato)nickel(II) and tris(imidazole-2-aldoximato)nickel(II) To generate NiIIFeIIINiII, MnIIINiII, NiIINiII, and ZnIINiII and the electrooxidized MnIVNiII, NiIINiIII, and ZnIINiIII species: a magnetostructural, electrochemical, and EPR spectroscopic study. Chaudhuri P; Weyhermüller T; Wagner R; Khanra S; Biswas B; Bothe E; Bill E Inorg Chem; 2007 Oct; 46(21):9003-16. PubMed ID: 17718561 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents. Hoener B; Engelstad BL; Ramos EC; Macapinlac HA; Price DC; Johnson TR; White DL J Magn Reson Imaging; 1991; 1(3):357-62. PubMed ID: 1802149 [TBL] [Abstract][Full Text] [Related]
9. NMR and EPR studies of low-spin Fe(III) complexes of meso-tetra-(2,6-disubstituted phenyl)porphyrinates complexed to imidazoles and pyridines of widely differing basicities. Watson CT; Cai S; Shokhirev NV; Walker FA Inorg Chem; 2005 Oct; 44(21):7468-84. PubMed ID: 16212373 [TBL] [Abstract][Full Text] [Related]
10. Accessibility and selective stabilization of the principal spin states of iron by pyridyl versus phenolic ketimines: modulation of the 6A1 ↔ 2T2 ground-state transformation of the [FeN4O2]+ chromophore. Shongwe MS; Al-Zaabi UA; Al-Mjeni F; Eribal CS; Sinn E; Al-Omari IA; Hamdeh HH; Matoga D; Adams H; Morris MJ; Rheingold AL; Bill E; Sellmyer DJ Inorg Chem; 2012 Aug; 51(15):8241-53. PubMed ID: 22808945 [TBL] [Abstract][Full Text] [Related]
11. pH-specific synthetic chemistry and solution studies in the binary system of iron(III) with the alpha-hydroxycarboxylate substrate quinic acid: potential relevance to iron chemistry in plant fluids. Menelaou M; Mateescu C; Zhao H; Rodriguez-Escudero I; Lalioti N; Sanakis Y; Simopoulos A; Salifoglou A Inorg Chem; 2009 Mar; 48(5):1844-56. PubMed ID: 19235948 [TBL] [Abstract][Full Text] [Related]
12. Structure-redox-relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes. Gale EM; Mukherjee S; Liu C; Loving GS; Caravan P Inorg Chem; 2014 Oct; 53(19):10748-61. PubMed ID: 25226090 [TBL] [Abstract][Full Text] [Related]
13. Novel iron(III) complexes of sterically hindered 4N ligands: regioselectivity in biomimetic extradiol cleavage of catechols. Mayilmurugan R; Stoeckli-Evans H; Palaniandavar M Inorg Chem; 2008 Aug; 47(15):6645-58. PubMed ID: 18597419 [TBL] [Abstract][Full Text] [Related]
14. Studies on the redox activity of iron N,O-complexes: Potential T Kuźnik N; Chmielniak U Redox Rep; 2016 Jan; 21(1):37-44. PubMed ID: 26023764 [TBL] [Abstract][Full Text] [Related]
15. Observation of redox-induced electron transfer and spin crossover for dinuclear cobalt and iron complexes with the 2,5-di-tert-butyl-3,6-dihydroxy-1,4-benzoquinonate bridging ligand. Min KS; Dipasquale AG; Rheingold AL; White HS; Miller JS J Am Chem Soc; 2009 May; 131(17):6229-36. PubMed ID: 19358538 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of Fe-(5-C2H5-EHPG)- as a contrast agent in MR imaging of hepatobiliary system. Sheu RS; Liu GC; Wang YM; Jaw TS; Chen HM; Kuo YT Kaohsiung J Med Sci; 1997 Feb; 13(2):75-85. PubMed ID: 9099045 [TBL] [Abstract][Full Text] [Related]
17. Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studies. Lauffer RB; Greif WL; Stark DD; Vincent AC; Saini S; Wedeen VJ; Brady TJ J Comput Assist Tomogr; 1985; 9(3):431-8. PubMed ID: 3989032 [TBL] [Abstract][Full Text] [Related]
18. Exchange interactions and zero-field splittings in C3-symmetric Mn(III)6Fe(III): using molecular recognition for the construction of a series of high spin complexes based on the triplesalen ligand. Glaser T; Heidemeier M; Krickemeyer E; Bögge H; Stammler A; Fröhlich R; Bill E; Schnack J Inorg Chem; 2009 Jan; 48(2):607-20. PubMed ID: 19072685 [TBL] [Abstract][Full Text] [Related]